ankylosing spondylitis

Lupin and Mylan Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept

Mumbai, June 04, 2020: Lupin Limited (Lupin) and Mylan N.V. (NASDAQ: MYL) today announced that the European Commission (EC) has…

4 years ago

BIOCAD and SPHagree to build a drug substance manufacturing facility in China

New Delhi, November 20, 2018: This yearat theEastern Economic Forum in Vladivostok, BIOCAD andShanghai Pharmaceuticals Holdingentered into a Memorandum of…

6 years ago

Interleukin-17 Inhibitor Shows High Efficacy After One Year of Therapy in Psoriasis Patients

New Delhi, April 28, 2018: In March 2018, BIOCAD analyzed results from its Phase II study in which the original…

7 years ago

Russian infliximab biosimilar has been proved equivalent to Remicade® in international clinical trials

New Delhi, February 21, 2018: In January 2018, BIOCAD’s infliximab biosimilar was approved in Russia. The approval was based on…

7 years ago